Frequently Asked Questions
The Middle East and Africa Blood Screening Market size will be worth USD 0.87 billion by 2029.
The Middle East and Africa Blood Screening Market growth rate will be 8.85% by 2029.
The emergence of new pathogens, rising investment rates for advanced technology development, a growing geriatric population, and favourable government blood screening policies are the growth drivers of the Middle East and Africa Blood Screening Market.
The products and services, technology, disease type and end user are the factors on which the Middle East and Africa Blood Screening Market research is based.
The major companies in the Middle East and Africa Blood Screening Market are Enzo Biochem Inc., Meridian Bioscience, Inc., BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., BioMérieux SA, Beckman Coulter, Inc., Abbott , F. Hoffmann-La Roche Ltd , Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc
